Aurobindo Pharma has received final approval from US Food and Drug Administration (US FDA) for tentatively approved ANDA for Perindopril Erbumine tablets 2mg, 4mg and 8mg.
Perindopril Erbumine tablets are the generic equivalent of Solay Pharmaceuticals' Aceon tablets and falls under the CVS segment and indicated for the treatment of patients with essential hypertension. The product will be launched shortly.
Aurobindo has a total of 109 ANDA approvals (81 final approvals and 28 tentative approvals) from US FDA.